IL6 and obesity disorder: Accumulated evidence has proved that TRF is a promising intervention against the worldwide trend of obesity.1 TRF is also associated with reductions in serum total cholesterol, triglycerides (TG), glucose, insulin, interleukin 6 (IL‐6), tumour necrosis factor‐α (TNF‐α), as well as with improvements in insulin sensitivity.2 Feeding behaviour is predominantly dictated by our inherent circadian clock, and this timing system and other factors like food availability, social habits and convenience jointly decide the way a life entity eats.